Abstract | CONTEXT: OBJECTIVE: PATIENT AND METHODS: CONCLUSION:
|
Authors | A A Nella, M B Lodish, E Fox, F M Balis, M M Quezado, P O Whitcomb, J Derdak, E Kebebew, B C Widemann, C A Stratakis |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 99
Issue 9
Pg. 3055-9
(Sep 2014)
ISSN: 1945-7197 [Electronic] United States |
PMID | 24617713
(Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Intramural)
|
Chemical References |
- Piperidines
- Quinazolines
- Adrenocorticotropic Hormone
- Protein-Tyrosine Kinases
- vandetanib
|
Topics |
- Adolescent
- Adrenocorticotropic Hormone
(metabolism)
- Carcinoma, Neuroendocrine
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Cushing Syndrome
(etiology)
- Humans
- Male
- Multiple Endocrine Neoplasia Type 2b
(complications)
- Neoplasms, Second Primary
(complications, metabolism, secondary)
- Piperidines
(therapeutic use)
- Protein-Tyrosine Kinases
(antagonists & inhibitors)
- Quinazolines
(therapeutic use)
- Thyroid Neoplasms
(complications, metabolism, secondary)
|